Healthcare provider profile · identity verified

Pamela Vandermark, NP

Nurse Practitioner · SHELBYVILLE, IN · NPI 1740557610

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	216	42
Levothyroxine Sodium	Levothyroxine Sodium	177	33
Metoprolol Succinate	Metoprolol Succinate	139	31
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	122	26
Gabapentin	Gabapentin	110	23
Tamsulosin Hcl	Tamsulosin Hcl	105	16
Eliquis	Apixaban	89	18
Furosemide	Furosemide	81	17
Pantoprazole Sodium	Pantoprazole Sodium	77	24
Buspirone Hcl	Buspirone Hcl	73	17
Clopidogrel	Clopidogrel Bisulfate	66	15
Prednisone	Prednisone	59	33
Tramadol Hcl	Tramadol Hcl	57	18
Torsemide	Torsemide	53	14
Amlodipine Besylate	Amlodipine Besylate	52	15
Trazodone Hcl	Trazodone Hcl	52	18
Clonidine Hcl	Clonidine Hcl	51	suppressed
Jardiance	Empagliflozin	50	13
Lisinopril	Lisinopril	48	12
Potassium Chloride	Potassium Chloride	48	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	42	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	41	suppressed
Losartan Potassium	Losartan Potassium	40	11
Sertraline Hcl	Sertraline Hcl	40	12
Ondansetron Hcl	Ondansetron Hcl	39	21
Carvedilol	Carvedilol	36	suppressed
Mirtazapine	Mirtazapine	36	suppressed
Spironolactone	Spironolactone	36	14
Omeprazole	Omeprazole	35	14
Lacosamide	Lacosamide	31	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	31	suppressed
Warfarin Sodium	Warfarin Sodium	31	suppressed
Pregabalin	Pregabalin	30	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	29	17
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	29	suppressed
Lorazepam	Lorazepam	28	suppressed
Nystatin	Nystatin	28	15
Allopurinol	Allopurinol	27	suppressed
Donepezil Hcl	Donepezil Hcl	27	suppressed
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	26	13
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	26	suppressed
Famotidine	Famotidine	23	suppressed
Fluticasone Propionate	Fluticasone Propionate	23	suppressed
Azithromycin	Azithromycin	22	15
Doxycycline Hyclate	Doxycycline Hyclate	22	18
Ezetimibe	Ezetimibe	22	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	18
Mesalamine Dr	Mesalamine	20	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Loperamide	Loperamide Hcl	19	suppressed
Oxycodone Hcl	Oxycodone Hcl	19	suppressed
Divalproex Sodium	Divalproex Sodium	18	suppressed
Mupirocin	Mupirocin	18	13
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Ozempic	Semaglutide	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Tradjenta	Linagliptin	17	suppressed
Alprazolam	Alprazolam	16	suppressed
Baclofen	Baclofen	16	suppressed
Glipizide	Glipizide	16	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Metformin Hcl	Metformin Hcl	16	suppressed
Olanzapine	Olanzapine	16	suppressed
Phenobarbital	Phenobarbital	16	suppressed
Cholestyramine	Cholestyramine (With Sugar)	15	suppressed
Gemtesa	Vibegron	15	suppressed
Calcitriol	Calcitriol	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Primidone	Primidone	14	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Finasteride	Finasteride	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Water	Water For Irrigation,sterile	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	11	suppressed
Linzess	Linaclotide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error